Fingerprint
Dive into the research topics of 'A phase 1b/pharmacokinetic trial of PTC299, a novel posttranscriptional VEGF inhibitor, for AIDS-related Kaposi's Sarcoma: AIDS malignancy consortium trial 059'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically